Close

Obagi Medical Products, Inc. (OMPI) Tops Q4 EPS by 5c

March 8, 2012 4:11 PM EST
Obagi Medical Products, Inc. (NASDAQ: OMPI) reported Q4 EPS of $0.24, $0.05 better than the analyst estimate of $0.19. Revenue for the quarter came in at $30.6 million versus the consensus estimate of $30.64 million.

For earnings history and earnings-related data on Obagi Medical Products, Inc. (OMPI) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings